2025. EVALUATION OF BIODEGRADABLE NANOCARRIERS FOR TARGETED DRUG DELIVERY IN HEPATOCELLULAR CARCINOMA. Frontier in Medical and Health Research. 3, 7 (Sep. 2025), 1259–1272.